Institutional Ownership Cullinan Oncology, Inc. (CGEM)
This table provides information about the institutional ownership of Cullinan Oncology, Inc. (CGEM). We have compiled data on the 118 institutions that hold shares in the stock, with a total of 42.8 Million shares, which have been reported (via 13F filing form) to have a value of $1.01 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2024 Q1 2024 |
7,648,268
shares
|
$180 Million
21.33% of portfolio
|
Q3 2021
Reduced 3.36%
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
3,414,189
shares
|
$80.2 Million
15.23% of portfolio
|
Q2 2023
Added 1.93%
|
|
Bvf Inc
San Francisco, CA |
May 15, 2024 Q1 2024 |
3,196,701
shares
|
$75.1 Million
1.63% of portfolio
|
Q1 2023
Reduced 57.43%
|
|
Blue Owl Capital Holdings LP
New York, NY |
May 15, 2024 Q1 2024 |
2,924,842
shares
|
$68.7 Million
13.21% of portfolio
|
Q1 2024
Reduced 14.47%
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2024 Q1 2024 |
2,696,762
shares
|
$63.4 Million
0.02% of portfolio
|
Q1 2024
Reduced 17.81%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
2,428,993
shares
|
$57.1 Million
0.0% of portfolio
|
Q1 2024
Reduced 1.35%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
1,774,345
shares
|
$41.7 Million
0.0% of portfolio
|
Q1 2024
Added 0.16%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
1,425,459
shares
|
$33.5 Million
0.0% of portfolio
|
Q1 2024
Added 152.11%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2024 Q1 2024 |
1,348,015
shares
|
$31.7 Million
0.86% of portfolio
|
Q1 2024
New holding
|
|
Braidwell LP
Stamford, CT |
May 15, 2024 Q1 2024 |
1,240,865
shares
|
$29.2 Million
0.68% of portfolio
|
Q4 2023
Reduced 34.99%
|
|
Nextech Invest Ag
|
May 15, 2024 Q1 2024 |
1,221,145
shares
|
$28.7 Million
3.89% of portfolio
|
Q4 2021
New holding
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,152,644
shares
|
$27.1 Million
0.0% of portfolio
|
Q1 2024
Added 25.3%
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
May 15, 2024 Q1 2024 |
1,138,531
shares
|
$26.8 Million
0.4% of portfolio
|
Q1 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
1,109,171
shares
|
$26.1 Million
0.0% of portfolio
|
Q1 2024
Reduced 2.09%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
993,377
shares
|
$23.3 Million
0.0% of portfolio
|
Q1 2024
Added 8.48%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2024 Q1 2024 |
950,000
shares
|
$22.3 Million
0.03% of portfolio
|
Q1 2024
New holding
|
|
Logos Global Management LP
San Francisco, CA |
May 15, 2024 Q1 2024 |
700,000
shares
|
$16.5 Million
1.11% of portfolio
|
Q1 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
677,330
shares
|
$15.9 Million
0.0% of portfolio
|
Q1 2024
Added 3.3%
|
|
Rubric Capital Management LP
New York, NY |
May 10, 2024 Q1 2024 |
626,929
shares
|
$14.7 Million
0.36% of portfolio
|
Q4 2022
Added 12.0%
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
571,138
shares
|
$13.4 Million
1.19% of portfolio
|
Q1 2024
Reduced 25.94%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 15, 2024 Q1 2024 |
549,276
shares
|
$12.9 Million
0.0% of portfolio
|
Q1 2024
Added 0.68%
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
517,606
shares
|
$12.2 Million
0.2% of portfolio
|
Q1 2024
Reduced 5.0%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 15, 2024 Q1 2024 |
420,217
shares
|
$9.88 Million
0.0% of portfolio
|
Q1 2024
Added 665.13%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
321,100
shares
|
$7.55 Million
0.01% of portfolio
|
Q1 2024
Added 21.59%
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
263,949
shares
|
$6.2 Million
0.0% of portfolio
|
Q1 2024
Reduced 1.11%
|